Press Releases
Kaiima Announces the Appointment of Dr. Mark Messmer to its Board of Directors
Kaiima and BioFields Unite to Form BioKaiima to Commercialize Castor Hybrid Seeds in Mexico
Kaiima and BASF Announce Trait Development Collaboration
Kaiima and Beck's Announce Strategic Corn Collaboration
Dr. Mark Messmer Appointed to Board
Kaiima and Horizon Ag Announce their Collaboration
Kaiima Announces the Growth and Expansion of its US Operations
Kaiima Announces Appointment of Richard Greubel as CEO, Dr. Doron Gal to Continue as President
Bayer CropScience and Kaiima Partner to Improve Rice Productivity
Kaiima and Keteng to Commercialize High-Yielding EP™ Corn Varieties
Kaiima Establishes U.S. office
Kaiima Named One of MIT Technology Review’s 50 Smartest Companies
Kaiima Closes Financing Round of More Than $65 Million
Kaiima Named as a Global Cleantech 100 Company
Saaten‐Union and Kaiima Join Forces for Creating a New Generation of Hybrid Wheat Varieties
February 15, 2017
Moshav Sharona, Israel
Kaiima Bio-Agritech Ltd. is pleased to announce the appointment of Dr. Mark Messmer to its Board of Directors.
Dr. Mark Messmer is currently engaged with Arvegenix in Pennycress crop R&D. Previously, Dr. Messmer led Monsanto’s North America Corn Breeding program, holding that position for 15 years. Dr. Messmer also led Monsanto's global hybrid wheat breeding program for 2 years in the late 1990's.
Prior to that, Dr. Messmer held various research and management positions, primarily focused on corn breeding
and breeding technology development over a period of 14 years, at Garst Seed Company.
Dr. Messmer holds a Master's and Ph.D. in Plant Breeding and Genetics from the University of Illinois.